What We Do

At CommonHealth Solutions, we work with pharmaceutical manufacturers to address market access challenges for existing products and prepare for the launch of new products. We collaborate with clients on go-to-market strategies, with an emphasis on understanding the environment in which their product competes and the payment and coverage policies that impact patients and providers. We also help health care payers understand the rapidly changing marketplace in which they compete and how they can better serve their members.

Our experience enables our clients to comprehend complex policies and how those policies will impact their products and the patients they serve. When legislative and regulatory issues come up, we develop and execute strategies to better approach them.

Together with each client, we will:

Icons-02.png

Review proposed regulatory actions from the Centers for Medicare and Medicaid Services, as well as Congressional and Presidential proposals, and analyze potential impact on manufacturers, providers, and patients.

Icons-03.png

Plan for the launch of new products and break down coding timelines and coverage and payment environments.

Icons-01.png

Address market access challenges for new and existing products with collaborative and innovative strategies.

We consider ourselves partners with our clients working towards a common goal. As such, we engage regularly with clients and continually refine our approach to ensure overall goals and objectives are met. Our flexibility allows us to deliver materials and communicate in the manner that works best for our clients. We tap into our experience and knowledge base in order to critically assess strategies and plans and make changes as needed.

Disclaimer: CommonHealth Solutions is not a registered lobbying firm, and therefore cannot participate in lobbying activities or lobbying contacts as defined under the Lobbying Disclosure Act (2 U.S.C. §1601 et. seq.) which would trigger lobbying disclosure requirements. For more information, please visit Lobbying Disclosure Act Guidance from the U.S. House of Representatives’ Office of the Clerk.